![Jane Grogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Grogan
Teknisk/Vetenskaplig/F&U Direktör på
BIOGEN INC.
Förmögenhet: 823 571 $ per 2026-07-31
Profil
Jane Grogan is Executive Vice President & Head-Research at Biogen, Inc. since 2023.
Former roles include Chief Scientific Officer at Graphite Bio, Inc. from 2021 to 2023, Chief Scientific Officer at Arsenal Biosciences, Inc. from 2019 to 2021, and Head-Adaptive Tumor Immunity & Principal Scientist at Genentech, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Melbourne and a doctorate from the University of Leiden.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOGEN INC. 0 % | 2026-02-13 | 4 058 ( 0 % ) | 823 571 $ | 2026-07-31 |
Aktiva positioner av Jane Grogan
| Företag | Position | Start |
|---|---|---|
| BIOGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-10-02 |
Tidigare kända positioner av Jane Grogan
| Företag | Position | Slut |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-01 |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Teknisk/Vetenskaplig/F&U Direktör | 2021-03-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2019-09-01 |
Jane Grogans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
97
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
